.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 31, 2022Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatreMedtronic plc, the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 82nd scientific sessions virtual meeting, June 3-7, 2022....
Apr 27, 2022Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) ConferenceMedtronic reported study results from the extended study phase of its MiniMed™ 780G system[i] pivotal trial with new data using its no-calibration, non-adjunctive Guardian™ 4 sensor[ii]. The...
- Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
Apr 20, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
Mar 14, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for continuous glucose monitoring (CGM), a key diabetes technology has been recently expanded or...
- Dec 22, 2021Medicare coverage for Medtronic customers will be available 60 days after official publication
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of...
- Dec 15, 2021
Medtronic plc (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the...
- Oct 19, 2021Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control
Medtronic plc (NYSE: MDT), a leading global healthcare technology company, recently announced one-year, real-world clinical data on 3,211 pediatric and adolescent patients with type 1 diabetes 15...
- Jun 28, 2021Data Were Presented at the American Diabetes Association 81st Scientific Sessions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The...
- Jun 23, 2021Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June...